XGEVA for Breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 23 adverse event reports in the FDA FAERS database where XGEVA was used for Breast cancer.
Most Reported Side Effects for XGEVA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 309 | 29.7% | 309 | 24 |
| Osteonecrosis of jaw | 159 | 15.3% | 5 | 14 |
| Investigation | 115 | 11.0% | 11 | 115 |
| Hospitalisation | 77 | 7.4% | 4 | 77 |
| Hypocalcaemia | 48 | 4.6% | 7 | 34 |
| Metastases to bone | 30 | 2.9% | 3 | 2 |
| Pain | 28 | 2.7% | 2 | 9 |
| Pain in extremity | 17 | 1.6% | 1 | 5 |
| Dyspnoea | 16 | 1.5% | 5 | 9 |
| Disease progression | 15 | 1.4% | 6 | 4 |
| Terminal state | 14 | 1.3% | 0 | 2 |
| Back pain | 13 | 1.3% | 0 | 2 |
| Fatigue | 13 | 1.3% | 1 | 4 |
| Hypoaesthesia | 13 | 1.3% | 5 | 6 |
| Malaise | 13 | 1.3% | 2 | 6 |
Other Indications for XGEVA
Metastases to bone (412)
Prophylaxis (385)
Product used for unknown indication (349)
Prostate cancer (32)
Prostate cancer metastatic (25)
Breast cancer metastatic (24)
Bone disorder (7)
Osteoporosis (6)
Neoplasm malignant (5)
Other Drugs Used for Breast cancer
TRASTUZUMAB (15,522)
PALBOCICLIB (13,075)
DOCETAXEL (11,735)
PACLITAXEL (10,215)
LETROZOLE (9,332)
CYCLOPHOSPHAMIDE (8,826)
PERTUZUMAB (7,532)
RIBOCICLIB (6,953)
CAPECITABINE (5,767)
EPIRUBICIN (5,444)